On Target Laboratories key facts
as of Oct 2026- Developer of a fluorescent imaging technology designed to target and illuminate cancer during surgery.
- On Target Laboratories is valued at approximately $65.6M as of Oct 2026 (last reported valuation).
- It has raised $134.4M; the latest was Later Stage VC ($19.6M) in Jan 2025.
- Notable investors include Elevate Ventures, Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC, H.I.G. Capital, Helsinn Healthcare — 14 tracked in total.
- Status: Privately Held (backing).
On Target Laboratories's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch On Target Laboratories: the Monday email on marks, rounds and moves
On Target Laboratories funding rounds
No funding rounds for On Target Laboratories are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs On Target Laboratories
14+Membership and data by Private Market View
On Target Laboratories valuation
On Target Laboratories's last reported valuation was $65.6 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
On Target Laboratories investors
14 investors are on record for On Target Laboratories, including Elevate Ventures, Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC and H.I.G. Capital.
About On Target Laboratories
Developer of a fluorescent imaging technology designed to target and illuminate cancer during surgery. The company's technology reduces the uncertainty associated with finding and removing diseased tissue during medical procedures, enabling surgeons to have the benefit of intraoperative sight.
- Sector
- Healthcare
- HQ
- West Lafayette, IN, United States
- Founded
- 2010
- Employees
- 45
- Website
- ontargetlabs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.